Skip to main content
Clinical Trials/ISRCTN11442818
ISRCTN11442818
Active, not recruiting
未知

Determinants of late diagnosis and delayed treatment cancer

World Health Organization Regional Office for Europe0 sites300 target enrollmentFebruary 7, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
World Health Organization Regional Office for Europe
Enrollment
300
Status
Active, not recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 7, 2022
End Date
December 1, 2026
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
World Health Organization Regional Office for Europe

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients who have confirmed breast, cervical, or childhood cancer
  • 2\. Older than 18 years (for adult cancers) or younger than 21 years (for childhood cancers)
  • 3\. Histology report available and confirms precancer lesion or invasive malignant cancer
  • 4\. New presented cases, up to 3 months from the day of first medical visit at the center
  • 5\. Agreed with informed consent to participate in the project

Exclusion Criteria

  • 1\. Cognitive or social disorder that impairs the ability to understand the interview
  • 2\. Ideally, a patient who is halfway through treatment should NOT be newly enrolled. An exception can be made in study sites with a low number of new cases or for low prevalent cancer types

Outcomes

Primary Outcomes

Not specified

Similar Trials